PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 8 filers reported holding PDL BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $0 | – | 291,360 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 291,360 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 291,360 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $720,000 | -60.2% | 291,360 | -49.3% | 0.05% | -11.9% |
| Q3 2020 | $1,809,000 | -26.3% | 574,423 | -31.9% | 0.06% | -6.3% |
| Q2 2020 | $2,453,000 | +36.5% | 842,950 | +32.3% | 0.06% | +34.0% |
| Q1 2020 | $1,797,000 | -71.5% | 637,311 | -67.2% | 0.05% | -47.2% |
| Q4 2019 | $6,308,000 | +85.6% | 1,943,774 | +23.5% | 0.09% | +122.5% |
| Q3 2019 | $3,399,000 | -22.0% | 1,573,780 | +13.5% | 0.04% | -52.9% |
| Q2 2019 | $4,355,000 | -12.3% | 1,386,885 | +3.9% | 0.08% | -15.0% |
| Q1 2019 | $4,966,000 | – | 1,334,943 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |